HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Asymmetric Total Synthesis of (-)-Englerin A through Catalytic Diastereo- and Enantioselective Carbonyl Ylide Cycloaddition.

Abstract
An asymmetric total synthesis of the guaiane sesquiterpene (-)-englerin A, a potent and selective inhibitor of the growth of renal cancer cell lines, was accomplished. The basis of the approach is a highly diastereo- and enantioselective carbonyl ylide cycloaddition with an ethyl vinyl ether dipolarophile under catalysis by dirhodium(II) tetrakis[N-tetrachlorophthaloyl-(S)-tert-leucinate], [Rh2 (S-TCPTTL)4 ], to construct the oxabicyclo[3.2.1]octane framework with concomitant introduction of the oxygen substituent at C9 on the exo-face. Another notable feature of the synthesis is ruthenium tetraoxide-catalyzed chemoselective oxidative conversion of C9 ethyl ether to C9 acetate.
AuthorsTaiki Hanari, Naoyuki Shimada, Yasunobu Kurosaki, Neetipalli Thrimurtulu, Hisanori Nambu, Masahiro Anada, Shunichi Hashimoto
JournalChemistry (Weinheim an der Bergstrasse, Germany) (Chemistry) Vol. 21 Issue 33 Pg. 11671-6 (Aug 10 2015) ISSN: 1521-3765 [Electronic] Germany
PMID26179743 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Chemical References
  • Antineoplastic Agents
  • Biological Factors
  • Coordination Complexes
  • Ethyl Ethers
  • Sesquiterpenes, Guaiane
  • dirhodium(II) tetrakis(N-tetrachlorophthaloyl-(S)-tert-leucinate)
  • englerin A
  • Rhodium
Topics
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Biological Factors (chemistry)
  • Catalysis
  • Cell Line, Tumor
  • Coordination Complexes (chemistry)
  • Cycloaddition Reaction
  • Ethyl Ethers (chemistry)
  • Humans
  • Kidney Neoplasms (chemistry, pathology)
  • Molecular Structure
  • Rhodium (chemistry)
  • Sesquiterpenes, Guaiane (chemical synthesis, chemistry)
  • Stereoisomerism

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: